A DNA Damage Repair Gene Signature Associated With Immunotherapy Response and Clinical Prognosis in Clear Cell Renal Cell Carcinoma

Background: Clear cell renal cell carcinoma (ccRCC) is the most common subtype in renal cell carcinoma with relatively poor clinical outcomes DNA damage repair genes (DDRGs) as potential biomarkers are rarely reported in predicting immunotherapy response and clinical prognosis for ccRCC. Methods: RN...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Linjie, Liang, Jiaming, Wang, Qi, Chen, Guodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152249/
https://www.ncbi.nlm.nih.gov/pubmed/35656315
http://dx.doi.org/10.3389/fgene.2022.798846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152249/
https://www.ncbi.nlm.nih.gov/pubmed/35656315
http://dx.doi.org/10.3389/fgene.2022.798846

Ejemplares similares